← Leaderboards
Patrick Anthony John Haslett
Rockefeller University
$1,657,967
Attributed
$1,657,967
Total exposure
6
Grants
0
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding mix
By agency
NIH$1,657,967 · 6
By mechanism
R01$1,398,924 · 1
M01$259,043 · 5
Top collaborators
No co-investigators on record.
Most similar at Rockefeller University
Same institution · by research overlap
- James G Krueger$4,444,811
- Stephen J Oliver$1,276,433
- Charles M. Rice$80,497,748
- Jean-Laurent Casanova$36,806,361
- Nina Bhardwaj$33,867,850
Others in their field
Top investigators on “Human Subject”
- Sonia M Thomas · Research Triangle Institute$701,865,642
- Tracy L Nolen · Research Triangle Institute$474,487,152
- George R Seage · Abt Associates, Inc.$172,422,660
- Jay Arnold Tischfield · Rutgers, The State Univ Of N.J.$160,455,836
- Jeffrey P Krischer · University Of South Florida$155,493,283
- Charles A Coltman · Southwest Oncology Group$154,811,913
Research focus
Human SubjectClinical ResearchThalidomideHuman Therapy EvaluationHiv InfectionsAids TherapyCombination ChemotherapyAntiaids AgentVirus ReplicationImmunoregulationT LymphocyteDrug Screening /EvaluationImmune Tolerance /UnresponsivenessAntiviral AgentsCell Cell InteractionClinical TrialsAntigen Presenting CellVirus RnaCellular ImmunityCytomegalovirusImmunomodulatorsMicroorganism Disease ChemotherapyPharmacokineticsPlacebos
Grant awards (15)
PHARMACOLOGIC T CELL COSTIMULATION IN HIV DISEASE$178,056
R01 · FY2005 · AI
PHARMOCOLOGICAL T-CELL COSTIMULATION IN HIV DISEASE$118,657
M01 · FY2005 · RR
INNATE IMMUNITY AND T CELL PRIMING IN HUMAN TUBERCULOSIS$410
M01 · FY2005 · RR
PHARMACOLOGIC T CELL COSTIMULATION IN HIV DISEASE$353,000
R01 · FY2004 · AI
PHARMOCOLOGICAL T-CELL COSTIMULATION IN HIV DISEASE$139,976
M01 · FY2004 · RR
PHARMACOLOGIC T CELL COSTIMULATION IN HIV DISEASE$353,000
R01 · FY2003 · AI
PHARMACOLOGIC T CELL COSTIMULATION IN HIV DISEASE$357,893
R01 · FY2002 · AI
PILOT STUDY OF THALIDOMIDE IN PYODERMA GANGRENOSUM$0
M01 · FY2002 · RR
THALIDOMIDE TREATMENT TO ENHANCE IMMUNE RESPONSE IN HIV INFECTION$0
M01 · FY2002 · RR
PHARMACOLOGIC T CELL COSTIMULATION IN HIV DISEASE$156,975
R01 · FY2001 · AI
PILOT STUDY OF THALIDOMIDE IN PYODERMA GANGRENOSUM$0
M01 · FY2001 · RR
THALIDOMIDE TREATMENT TO ENHANCE IMMUNE RESPONSE IN HIV INFECTION$0
M01 · FY2001 · RR
THALIDOMIDE TREATMENT TO ENHANCE IMMUNE RESPONSE IN HIV INFECTION$0
M01 · FY2000 · RR
IMMUNE RESPONSE TO KLH VACCINATION IN HIV INFECTED$0
M01 · FY2000 · RR
PILOT STUDY OF THALIDOMIDE IN PYODERMA GANGRENOSUM$0
M01 · FY2000 · RR